Sort by
Refine Your Search
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
Number: 6572065 Postdoctoral Research Associate - Experimental Particle Physics Group About the Opportunity The Experimental Particle Physics group at Northeastern University in Boston has an immediate
-
Discovery) in the Department of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, Boston. Thakur Lab has been at the forefront in developing GPCR (cannabinoid receptors 1 and
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
of Chemistry and Chemical Biology at Northeastern University is searching for an enthusiastic Postdoctoral Research Associate to join our multidisciplinary team. Our group integrates organic, inorganic, and
-
opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
fellows an opportunity to work with our innovative biopharmaceutical industry partners while collaborating with Northeastern University faculty in professional and career development, service, scholarship
-
Professor Lei Xie seek to hire Postdoctoral Research Associates to train in and oversee in interdisciplinary projects involving AI algorithm development, physiologically based pharmacokinetics, computational
-
Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year